DEGREE OF THROMBOCYTOPENIA AS AN INDICATOR OF SEVERITY OF LIVER DISEASE IN PATIENTS EVALUATED FOR OR AWAITING LIVER TRANSPLANTATION

(1) Department of Medicine, Columbia University College of Physicians and Surgeons

(2) Clinical Trials Office, Columbia University Medical Center, New York

(3) Department of Medicine

(4) Liver Transplantation, Beth Israel Deaconess Medical Centre, Boston

(5) Division of Gastroenterology, University of Pennsylvania, Philadelphia

(6) Liver Disease and Transplant Center, Cedars-Sanai, Los Angeles

(7) Liver Disease and Transplant Center, Mount Sinai, New York

(8) Department of Gastroenterology, Mayo Clinic, Rochester

(9) Department of Gastroenterology, UCLA, Los Angeles

(10) Research, GlaxoSmithKline, Rochester

(11) Global Health Outcomes, GlaxoSmithKline, Collegeville, United States

(12) Biostatistics and Data Analysis

(13) Health Care Data Capture, United BioSource Corporation, Montreal, Canada



This item was part of the LIVER III session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A493